JP2018511325A5 - - Google Patents

Download PDF

Info

Publication number
JP2018511325A5
JP2018511325A5 JP2017550936A JP2017550936A JP2018511325A5 JP 2018511325 A5 JP2018511325 A5 JP 2018511325A5 JP 2017550936 A JP2017550936 A JP 2017550936A JP 2017550936 A JP2017550936 A JP 2017550936A JP 2018511325 A5 JP2018511325 A5 JP 2018511325A5
Authority
JP
Japan
Prior art keywords
got1
polypeptide
purifying
preparation
sumo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017550936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018511325A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2016/050346 external-priority patent/WO2016157190A1/en
Publication of JP2018511325A publication Critical patent/JP2018511325A/ja
Publication of JP2018511325A5 publication Critical patent/JP2018511325A5/ja
Pending legal-status Critical Current

Links

JP2017550936A 2015-03-31 2016-03-31 グルタミン酸オキサロ酢酸トランスアミナーゼ1(got1)、その調製物および製造方法およびその使用 Pending JP2018511325A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562140492P 2015-03-31 2015-03-31
US62/140,492 2015-03-31
PCT/IL2016/050346 WO2016157190A1 (en) 2015-03-31 2016-03-31 Glutamate oxaloacetate transaminase 1 (got1), preparations and methods of generating same and uses thereof

Publications (2)

Publication Number Publication Date
JP2018511325A JP2018511325A (ja) 2018-04-26
JP2018511325A5 true JP2018511325A5 (enExample) 2019-04-11

Family

ID=55795016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017550936A Pending JP2018511325A (ja) 2015-03-31 2016-03-31 グルタミン酸オキサロ酢酸トランスアミナーゼ1(got1)、その調製物および製造方法およびその使用

Country Status (11)

Country Link
US (1) US20180071369A1 (enExample)
EP (1) EP3277308A1 (enExample)
JP (1) JP2018511325A (enExample)
KR (1) KR20170132293A (enExample)
CN (1) CN107771217A (enExample)
AU (1) AU2016242298A1 (enExample)
BR (1) BR112017021016A2 (enExample)
CA (1) CA2979309A1 (enExample)
HK (1) HK1243329A1 (enExample)
RU (1) RU2017135552A (enExample)
WO (1) WO2016157190A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018229764A1 (en) 2017-06-13 2018-12-20 Yeda Research And Development Co. Ltd. Treatment of advanced or progressive multiple sclerosis
RU2712193C1 (ru) * 2018-07-27 2020-01-24 Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") Способ лечения поражения нервной системы с помощью рекомбинантной глутаматоксалоацетаттрансаминазы
US11740211B2 (en) * 2020-01-31 2023-08-29 Waters Technologies Corporation LC/MS adduct mitigation by vapor deposition coated surfaces
CN116143898B (zh) * 2023-01-30 2026-03-24 翌圣生物科技(上海)股份有限公司 骨形态发生蛋白bmp-2重组蛋白、编码基因及其原核表达方法
CN118147225A (zh) * 2024-03-25 2024-06-07 华中农业大学 黄颡鱼去sumo化修饰体系及其构建方法和应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
CA2472477C (en) * 2002-01-07 2012-03-20 Lifesensors, Inc. Methods and compositions for protein expression and purification
EP2561889A3 (en) * 2002-08-01 2013-04-03 Yeda Research and Development Co. Ltd. Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
GB0315248D0 (en) * 2003-06-30 2003-08-06 Hoffmann La Roche HCV regulated protein expression
EP1765857A2 (en) * 2004-07-02 2007-03-28 Metanomics GmbH Process for the production of fine chemicals
CA2585798A1 (en) * 2004-12-17 2006-06-17 Metanomics Gmbh Process for the control of production of fine chemicals
US8119369B2 (en) 2004-12-30 2012-02-21 Lifesensors, Inc. Human SUMO-3 for enhancing protein expression
US20100048480A1 (en) * 2006-11-22 2010-02-25 Bettina Bommarius Production of anti-microbial peptides
JP5469786B2 (ja) * 2006-12-29 2014-04-16 ライフセンサーズ、インク. タンパク質の発現増強および精製の方法および組成
PT2415779E (pt) * 2010-08-02 2015-05-13 Ratiopharm Gmbh Processo de produção e purificação de uma sialiltransferase solúvel activa
EP2714727B1 (en) * 2011-05-24 2014-10-22 Asociación Centro de Investigación Cooperativa en Biociencias-CIC Biogune High affinity sumo traps

Similar Documents

Publication Publication Date Title
HRP20201973T1 (hr) Ligandi modificirani kružnom permutacijom kao agonisti i antagonisti
JP2018510132A5 (enExample)
HRP20210874T1 (hr) Imunomodulatorni proteini s prilagodljivim afinitetima
JP2016519137A5 (enExample)
FI3461261T3 (fi) Yksiketjuisen vaihtelevan fragmentin sisältäviä cd3:a sitovia proteiineja
JP2008505133A5 (enExample)
JP2011528896A5 (enExample)
JP2016525545A5 (enExample)
FI3694529T3 (fi) Trispesifiset proteiinit ja niiden käyttömenetelmät
AR086360A1 (es) Polipeptidos anticuerpos que antagonizan cd40
JP2017160222A5 (enExample)
JP2016534052A5 (enExample)
JP2019507781A5 (enExample)
HRP20201031T1 (hr) Anti-ctla-4 protutijela i postupci njihove upotrebe
JP2010502207A5 (enExample)
JP2011528895A5 (enExample)
JP2013537416A5 (enExample)
HRP20201528T1 (hr) Biparatopikalni polipeptidi koji antagoniziraju wnt signalizaciju u tumorskim stanicama
IL278014B2 (en) Anti-myostatin antibodies, polypeptides containing variable FC regions and methods of use
IL288541B (en) Vaccine against rsv
JP2013236633A5 (enExample)
JP2017514522A5 (enExample)
HRP20241103T1 (hr) 2,4-di-(skupina koja sadrži dušik)-supstituirani pirimidinski spoj i postupak pripreme i njegova upotreba
JP2014511680A5 (enExample)
JP2019535267A5 (enExample)